English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Town of Wallkill bans vaping on public property following youth advocacy
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Merck ends talks with Revolution Medicines over acquisition price disagreement
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Sarepta reports sustained benefit from DMD gene therapy three years after treatment
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Corcept reports positive Phase III results for ovarian cancer drug relacorilant
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Study finds tertiary treatment reduces antibiotic resistance transfer from reclaimed irrigation water
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Review highlights possible link between microplastics exposure and Parkinson’s disease mechanisms

Trending
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones